HRP20080184T3 - Azabiciklički derivati, postupak njihove pripravei farmaceutski pripravci koji ih sadrže - Google Patents
Azabiciklički derivati, postupak njihove pripravei farmaceutski pripravci koji ih sadržeInfo
- Publication number
- HRP20080184T3 HRP20080184T3 HR20080184T HRP20080184T HRP20080184T3 HR P20080184 T3 HRP20080184 T3 HR P20080184T3 HR 20080184 T HR20080184 T HR 20080184T HR P20080184 T HRP20080184 T HR P20080184T HR P20080184 T3 HRP20080184 T3 HR P20080184T3
- Authority
- HR
- Croatia
- Prior art keywords
- group
- alkyl
- inclusive
- atom
- different
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- -1 mercapto, hydroxy Chemical group 0.000 abstract 4
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004442 acylamino group Chemical group 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004419 alkynylene group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Spoj formule (I) naznačen time, da• m i n, koji mogu biti jednaki ili različiti, označavaju cijeli broj koji se nalazi u rasponu od uključivo 0i 2, a zbroj ta dva cijela broja nalazi se u rasponu od uključivo 2 i 3, • p i q, koji mogu biti jednaki ili različiti, označavaju cijeli broj koji se nalazi u rasponu od uključivo 0 i 2, • Alk predstavlja alkilenski, alkenilenski ili alkinilenski lanac, • Y i Y', koji mogu biti jednaki ili različiti, predstavljaju atom vodika, halogena, ili skupinu alkil, alkoksi, alkiltio, alkilsulfinil, alkilsulfonil, merkapto, hidroksi, perhalogenalkil, nitro, amino (nesupstituiran ili supstituiran s jednom ili dvije skupine alkil), acil,aminokarbonil (po izboru supstituiran na atomu dušika s jednom ili dvije skupine alkil), acilamino (po izboru supstituiran na atomu dušika sa skupinom alkil), alkoksikarbonil, karboksi, sulfo ili cijano, • X predstavlja atom kisika, sumpora ili skupinu -N(R)-, pri čemu R predstavlja atom vodika ili skupinu alkil, • W predstavlja skupinu odabranu između cijano (kada X predstavlja atom kisika ili skupinu -N(R1-), -N(R1)-Z1-R2 i -Z2-NR1R2,pri čemu: - Z1 predstavlja -C(O)-, -C(S), -C(NR*)-, *-C(CO-N(R3)-, *-C(S)-N(R3)-, *-C(NR4)-N(R3)-, *-C(O)-O-,
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0401690A FR2866647B1 (fr) | 2004-02-20 | 2004-02-20 | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2005/000382 WO2005089747A1 (fr) | 2004-02-20 | 2005-02-18 | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20080184T3 true HRP20080184T3 (hr) | 2008-05-31 |
| HRP20080184T5 HRP20080184T5 (hr) | 2008-10-31 |
Family
ID=34833930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20080184T HRP20080184T5 (hr) | 2004-02-20 | 2008-04-22 | Azabiciklički derivati, postupak njihove pripravei farmaceutski pripravci koji ih sadrže |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7576120B2 (hr) |
| EP (1) | EP1720544B1 (hr) |
| JP (1) | JP4519861B2 (hr) |
| KR (1) | KR100885104B1 (hr) |
| CN (2) | CN100577160C (hr) |
| AR (3) | AR047685A1 (hr) |
| AT (1) | ATE389398T1 (hr) |
| AU (1) | AU2005224129B2 (hr) |
| BR (1) | BRPI0507830A (hr) |
| CA (1) | CA2555216C (hr) |
| CY (1) | CY1108529T1 (hr) |
| DE (1) | DE602005005456T2 (hr) |
| DK (1) | DK1720544T3 (hr) |
| EA (1) | EA010300B1 (hr) |
| ES (1) | ES2303233T3 (hr) |
| FR (1) | FR2866647B1 (hr) |
| GE (1) | GEP20094578B (hr) |
| HK (1) | HK1123789A1 (hr) |
| HR (1) | HRP20080184T5 (hr) |
| MA (1) | MA28342A1 (hr) |
| ME (1) | ME01400B (hr) |
| MY (1) | MY137282A (hr) |
| NO (1) | NO337013B1 (hr) |
| NZ (1) | NZ548898A (hr) |
| PL (1) | PL1720544T3 (hr) |
| PT (1) | PT1720544E (hr) |
| RS (1) | RS50577B (hr) |
| SI (1) | SI1720544T1 (hr) |
| WO (1) | WO2005089747A1 (hr) |
| ZA (1) | ZA200606558B (hr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1717235A3 (en) * | 2005-04-29 | 2007-02-28 | Bioprojet | Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands |
| EP1717234A1 (en) * | 2005-04-29 | 2006-11-02 | Bioprojet | Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands |
| US20090023731A1 (en) * | 2007-03-22 | 2009-01-22 | Arete Therapeutics, Inc. | Soluble epoxide hydrolase inhibitors |
| FR2932479A1 (fr) | 2008-06-13 | 2009-12-18 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| FR2937251B1 (fr) * | 2008-10-16 | 2011-03-18 | Servier Lab | Utilisation du 4-{3-°hexahydrocyclopenta°c!pyrrol-2(1h)-yl! propoxy}benzamide pour l'obtention de medicaments destines au traitement des troubles du sommeil |
| FR2953513B1 (fr) | 2009-12-09 | 2011-12-23 | Servier Lab | Nouveaux derives azabicyclo[3.2.0]hept-6-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2953521B1 (fr) * | 2009-12-09 | 2011-11-18 | Servier Lab | Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2953514B1 (fr) * | 2009-12-09 | 2011-12-23 | Servier Lab | Nouveaux derives azabicyclo[3.2.0]hept-3-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2953515B1 (fr) | 2009-12-09 | 2011-12-23 | Servier Lab | Nouveaux derives du type hexahydrocyclopenta[b]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2974729B1 (fr) * | 2011-05-02 | 2013-04-19 | Servier Lab | Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide et un inhibiteur de l'acetylcholinesterase et les compositions pharmaceutiques qui la contiennent |
| FR2976286B1 (fr) * | 2011-06-08 | 2013-05-24 | Servier Lab | 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent |
| FR2976285B1 (fr) * | 2011-06-08 | 2013-05-24 | Servier Lab | Procede de synthese et forme cristalline du chlorhydrate de 4-{3-[cis-hexahydrocypenta[c]pyrrol-2(1h)-yl]propoxy}benzamide ainsi que les compositions pharmaceutiques qui la contiennent |
| SG11201402963TA (en) | 2011-12-08 | 2014-09-26 | Taisho Pharmaceutical Co Ltd | Phenylpyrrole derivative |
| FR2983732B1 (fr) * | 2011-12-09 | 2013-11-22 | Servier Lab | Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}pharmaceutiques qui la contiennent |
| JPWO2013100054A1 (ja) * | 2011-12-27 | 2015-05-11 | 大正製薬株式会社 | フェニルトリアゾール誘導体 |
| CN103183632A (zh) * | 2011-12-29 | 2013-07-03 | 山东方明药业集团股份有限公司 | 一种3-氮杂双环辛烷盐酸盐的提纯方法 |
| FR2999179A1 (fr) | 2012-12-07 | 2014-06-13 | Servier Lab | Procede de synthese d'un sel d'addition a un acide pharmaceutiquement acceptable du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, ainsi que les formes cristallines associees |
| FR3003466B1 (fr) * | 2013-03-22 | 2015-08-07 | Servier Lab | Utilisation du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide pour le traitement des douleurs neuropathiques |
| EP3594205A1 (en) | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-aryl derivatives for treating a rna virus infection |
| EP3594206A1 (en) * | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-quinoline derivatives for treating a rna virus infection |
| CN111377846B (zh) * | 2018-12-27 | 2022-05-24 | 江苏恩华药业股份有限公司 | 一种哌嗪苯甲酰胺类衍生物及其应用 |
| CN111377911B (zh) * | 2018-12-27 | 2022-05-24 | 江苏恩华药业股份有限公司 | 一种吗啉苯甲酰胺类化合物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2962496A (en) * | 1957-01-28 | 1960-11-29 | Geschickter Fund Med Res | Nu-substituted-3-azabicyclooctanes [3: 3: 0] and salts thereof |
| DE4341403A1 (de) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
| JP2004502664A (ja) * | 2000-06-30 | 2004-01-29 | イーラン ファーマスーティカルズ、インコーポレイテッド | アルツハイマー病処置用化合物 |
| AU2001273384A1 (en) * | 2000-07-13 | 2002-01-30 | Abbott Laboratories | 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| FR2827288B1 (fr) * | 2001-07-12 | 2003-10-31 | Servier Lab | Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2004
- 2004-02-20 FR FR0401690A patent/FR2866647B1/fr not_active Expired - Fee Related
-
2005
- 2005-02-18 CN CN200580005456A patent/CN100577160C/zh not_active Expired - Fee Related
- 2005-02-18 MY MYPI20050619A patent/MY137282A/en unknown
- 2005-02-18 ME MEP-2008-947A patent/ME01400B/me unknown
- 2005-02-18 AU AU2005224129A patent/AU2005224129B2/en not_active Ceased
- 2005-02-18 CA CA2555216A patent/CA2555216C/fr not_active Expired - Fee Related
- 2005-02-18 JP JP2006553623A patent/JP4519861B2/ja not_active Expired - Fee Related
- 2005-02-18 PT PT05717646T patent/PT1720544E/pt unknown
- 2005-02-18 AR ARP050100585A patent/AR047685A1/es active IP Right Grant
- 2005-02-18 EA EA200601512A patent/EA010300B1/ru not_active IP Right Cessation
- 2005-02-18 WO PCT/FR2005/000382 patent/WO2005089747A1/fr active Application Filing
- 2005-02-18 CN CN2008100828098A patent/CN101230033B/zh not_active Expired - Fee Related
- 2005-02-18 EP EP05717646A patent/EP1720544B1/fr active Active
- 2005-02-18 AT AT05717646T patent/ATE389398T1/de active
- 2005-02-18 KR KR1020067019301A patent/KR100885104B1/ko not_active IP Right Cessation
- 2005-02-18 SI SI200530217T patent/SI1720544T1/sl unknown
- 2005-02-18 RS RSP-2008/0226A patent/RS50577B/sr unknown
- 2005-02-18 DK DK05717646T patent/DK1720544T3/da active
- 2005-02-18 NZ NZ548898A patent/NZ548898A/en not_active IP Right Cessation
- 2005-02-18 DE DE602005005456T patent/DE602005005456T2/de active Active
- 2005-02-18 BR BRPI0507830-0A patent/BRPI0507830A/pt not_active IP Right Cessation
- 2005-02-18 ES ES05717646T patent/ES2303233T3/es active Active
- 2005-02-18 GE GEAP20059627A patent/GEP20094578B/en unknown
- 2005-02-18 PL PL05717646T patent/PL1720544T3/pl unknown
- 2005-02-20 US US10/589,831 patent/US7576120B2/en not_active Expired - Fee Related
-
2006
- 2006-08-03 MA MA29229A patent/MA28342A1/fr unknown
- 2006-08-07 ZA ZA2006/06558A patent/ZA200606558B/en unknown
- 2006-09-14 NO NO20064160A patent/NO337013B1/no not_active IP Right Cessation
-
2008
- 2008-04-22 HR HR20080184T patent/HRP20080184T5/hr unknown
- 2008-05-20 CY CY20081100520T patent/CY1108529T1/el unknown
-
2009
- 2009-01-09 HK HK09100237.4A patent/HK1123789A1/xx not_active IP Right Cessation
-
2012
- 2012-12-26 AR ARP120104964A patent/AR089451A2/es unknown
-
2014
- 2014-01-28 AR ARP140100250A patent/AR094601A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20080184T3 (hr) | Azabiciklički derivati, postupak njihove pripravei farmaceutski pripravci koji ih sadrže | |
| ATE303357T1 (de) | Amid-derivate | |
| RS52061B (en) | PIRAZOLYL-AMINOPYRIDINE DERIVATIVES USEFUL AS KINASE INHIBITORS | |
| ATE453631T1 (de) | Pna-monomer und vorstufe | |
| RS49532B (sr) | Inkluzioni kompleksi aril-heterocikličnih soli | |
| HUP0303360A2 (hu) | Maláriaellenes hatású szubsztituált amino-aza-cikloalkánok és ezeket tartalmazó gyógyszerkészítmények | |
| AR066012A1 (es) | Derivados oxazolidinona, medicamento, composicion farmaceutica y uso en infecciones bacterianas | |
| TW200617002A (en) | Novel substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | |
| HUP0301045A2 (hu) | Kinolinonszármazékok mint tirozin kináz inhibitorok, ezeket tartalmazó gyógyszerkészítmények | |
| HUP0302412A2 (hu) | Foszfodiészteráz gátlására alkalmazható béta-karbolin-származékok és az ezeket tartalmazó gyógyszerkészítmények | |
| ATE188464T1 (de) | Substituierte amidderivate | |
| RS54667B1 (en) | CYTOTOXIC BENZODIAZEPINE DERIVATIVES | |
| HRP20020247B1 (hr) | Antivirusni pripravci | |
| ATE447569T1 (de) | Pna-monomer und vorstufe | |
| AR072471A1 (es) | BENZOXACINAS Y BENZOTIACINAS CON ACTIVIDAD INHIBIDORA DE NOS, COMPOSICIoN FARMACÉUTICA QUE LAS COMPRENDE Y SU USO EN EL TRATAMIENTO DEL DOLOR. | |
| HUP0104188A2 (hu) | Antranilsav- és tioantranilsav-N-aril-amidok, előállításuk és alkalmazásuk VEGF receptor tirozinkináz inhibítorokként | |
| DE60206111D1 (de) | Selbstbräunendes Mittel enthaltend einen Ester von einer N-Acyl Aminosäure | |
| ATE277889T1 (de) | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha | |
| HUP9903216A2 (hu) | Helyettesített benzamidok, valamint alkalmazásuk hatóanyagként gyógyászati készítményekben | |
| AR018159A1 (es) | Compuestos derivados de amidin-amino-acidos halogenados utiles como inhibidores de la oxido-nitrico-sintetasa, composicion farmaceutica que los contiene ymetodo de tratamiento | |
| HUP0203184A2 (hu) | Izoxazolkarboxamid-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0302193A2 (hu) | 1,4-Diazabiciklo[3.2.2]nonán-benzoxazol,-benzotiazol és -benzimidazol-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
| ATE277897T1 (de) | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha | |
| DE69615555D1 (de) | 6-carboxamido-dihydropyran-derivate | |
| AR035285A1 (es) | Formulaciones en combinacion de derivados de1,4-benzotiepina-1,1-dioxido con otras sustancias activas, y su utilizacion. |